Navigation Links
uniQure Initiates Phase I in Acute Intermittent Porphyria
Date:12/11/2012

AMSTERDAM, December 11, 2012 /PRNewswire/ --

uniQure B.V., a leader in the field of human gene therapy, today announced the start of its Phase I clinical trial in acute intermittent porphyria (AIP) with the treatment of the first patient. The study is conducted under the aegis of the AIPGENE consortium, a pan-European collaboration funded in part by the European Commission's Seventh Framework Program with the aim to develop a gene therapy for the treatment of AIP, a rare and devastating disease caused by mutations in the porphobilinogen deaminase gene (PBGD). AIP can be life-threatening and the long-term effects include irreversible nerve damage, liver cancer and kidney failure. uniQure was granted orphan drug designation for the treatment of AIP in 2009 from the European Medicines Agency.

"The start of the AIP Phase I study marks the first of four programs that will enter clinical trials over the next 12 months," says Jörn Aldag, CEO of uniQure.  "After AIP we expect clinical trials to be initiated in Parkinson's disease, hemophilia B, and Sanfilippo B. After many years of building and developing our capabilities and competencies, and the approval in November of Glybera for LPLD as the first gene therapy in the Western world, we are highly motivated to expedite the clinical development of our other advanced gene therapies."

About the AIP Phase I study

The Phase I will enroll eight patients with severe AIP at two centers: the Clinical University of Navarra, Pamplona, Spain, and the 12 de Octubre University Hospital,, Madrid, Spain. The study's primary objective is the assessment of safety and determination of the maximum tolerated dose.  Secondary objectives include tolerability of treatment, pharmacokinetics, changes in the levels of surrogate markers of activity including porphobilinogen (PBG) and delta-aminolevulinic acid (ALA), and assessment of symptom control, neuro-psychological changes and quality of life. All pa
'/>"/>

SOURCE uniQure B.V.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. uniQure Appoints Hans Christian Rohde Chief Commercial Officer
2. uniQure Licenses RNA Interference Technology to Advance Huntingtons Disease Program
3. Fate Therapeutics Initiates Phase 2 Clinical Study of ProHema for the Treatment of Hematologic Malignancies
4. The Acute Liver Failure Study Group Initiates Phase 2a Study of OCR-002 for Treatment of Acute Liver Failure after Acetaminophen Overdose
5. Isis Pharmaceuticals Initiates Phase 1b/2a Study Of ISIS-SMNRx In Patients With Spinal Muscular Atrophy
6. Isis Initiates Phase 2 Study Of ISIS-FXIRX In Patients Undergoing Knee Replacement Surgery
7. Synthetic Biologics Initiates Development of Monoclonal Antibodies for Treatment of Acinetobacter Infections
8. Healthpoint Biotherapeutics Initiates Phase III Study of Unique Investigational Cell-Based Therapy for Venous Leg Ulcers
9. New Jersey Health Foundation Initiates Program To Spur Innovative Research
10. Rigel Initiates Phase 2 Clinical Studies with R343 for Asthma and R333 for Discoid Lupus
11. ImmusanT Initiates Clinical Trials of Nexvax2 Therapeutic Vaccine for Celiac Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... 2013   National Community Pharmacists Association (NCPA) ... MBA issued the following statement today regarding a ... D "preferred pharmacy" drug plans , which often ... lowest advertised co-payments: (Logo:  http://photos.prnewswire.com/prnh/20100106/DC33253LOGO ) ... MedPAC , 16 U.S. Senators and ...
(Date:5/20/2013)... 20, 2013  Hill-Rom Holdings, Inc. (NYSE: ... presentation at the 38 th Annual Deutsche Bank ... on May 30, 2013, at 1:30 p.m. EDT. ... are invited to listen to the live discussion via ... it directly at http://www.media-server.com/m/p/f7bj3q84 . A recorded replay ...
(Date:5/20/2013)... May 20, 2013 Sequent Medical, Inc. announced ... SL ("Single Layer") family of WEB ® Aneurysm ... these new models in select neurovascular centers in Europe.  ... navigability that will enable physicians to treat a broader ... The SL configurations are made possible by further advancement ...
Breaking Medicine Technology:Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 2Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 3Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 4Sequent Medical, Inc. Launches New SL Family of WEB Aneurysm Embolization Devices 2
... , , , , PORTSMOUTH, Va., Dec. ... away over $6,000,000 worth of its new LifeGuard30(TM) medical ... afford to buy them as well as to charitable and non-profit ... stores and displays vital patient information at the scene of a ...
... , , , , , , SEATTLE, Dec. ... today that on December 24, 2009, CTI,s Board of Directors (the ... "Rights Plan") in which one preferred stock purchase right will be ... business on January 7, 2010. Initially, the rights are not exercisable, ...
Cached Medicine Technology:ViVre Medical Announces $6,000,000 Gift 2ViVre Medical Announces $6,000,000 Gift 3Cell Therapeutics, Inc. Adopts Shareholder Rights Plan 2Cell Therapeutics, Inc. Adopts Shareholder Rights Plan 3Cell Therapeutics, Inc. Adopts Shareholder Rights Plan 4
(Date:5/20/2013)... 20, 2013 Fastcare Miami Beach clinic ... (UTI) within its first symptoms, as if not treated, it ... more serious infection. Although a urinary tract infection in itself ... to serious kidney infection called pyelonephritis. Women seem to have ... up to the same percentage as women after the age ...
(Date:5/20/2013)... In order to prepare for the long ... from DrSmartphoneMD launched an article series to raise awareness about ... series launched with the precautions that need to be ... program are not one of the 3.5 million cases of ... 90% of all skin cancer cases are associated with exposure ...
(Date:5/20/2013)... May 20, 2013 Eben ... to the public creating a frenzy among business ... this elite business training. WealthSpringMarketing.com's Tiffany Hendricks has ... as an exclusive bonus. , "Eben Pagan is ... business training to individuals serious about success," reports ...
(Date:5/20/2013)... 20, 2013 Parker Waichman LLP, a ... victims injured by defective drugs, has filed a lawsuit ... that use of the diabetes drug medication Actos ... on April 30, 2013, in the U.S. District Court ... where it is one of thousands of cases pending ...
(Date:5/20/2013)... 2013 Leading facial plastic surgeon and ENT ... a “Top Doc” in the field of Otolaryngology in the ... The Palm Beacher magazine, one of Palm Beach County’s leading ... the May/June 2013 issue, including 70 of the very best ... events, things to do, health and fitness, people to watch, ...
Breaking Medicine News(10 mins):Health News:Fastcare Advises on How to Prevent a UTI 2Health News:Combat Skin Cancer In Summer Months 2Health News:Eben Pagan's Accelerate: Review and Bonus Released By WealthSpringMarketing.com 2Health News:Taking Actos for Two Years Caused Bladder Cancer, Alleges Lawsuit Filed by Parker Waichman LLP on Behalf of South Dakota Man 2Health News:Dr. Schwartz Named “Top Doc” by The Palm Beacher Magazine 2
... working with an international team of health and ... to provide long-term weather forecasts to medical officials ... The forecasts will enable local health providers to ... disease, which is correlated with dry and dusty ...
... 19 Medipacs, Inc., a Tucson based drug,delivery device company ... Invest Southwest Capital Conference to be held in Scottsdale,AZ on ... One of only 12 companies to present at ... of high-tech fields. "Generally,speaking, (the businesses) have to be highly ...
... consumers filed a proposed,nationwide class-action lawsuit earlier this week ... BAY), alleging the pharmaceutical giant,skirted FDA requirements in marketing ... (Logo: http://www.newscom.com/cgi-bin/prnh/20080317/AQM144LOGO ) , ... markets two of its over-the-counter products --,Bayer Aspirin with ...
... A. Hoke,has joined the Sisters of Charity Health System ... for the Cleveland-,based organization and its 20 health and ... announcement was made by Sisters of Charity Health System,President ... "We are pleased to ...
... Nov. 19 Healthcare Management Systems,Inc.(R) (HMS) presented the 4th Annual ... the healthcare field. The awards were,presented Friday, October 17, during the ... Awards were presented to the following nominees: , ... Respiratory Care Center, Inc., Mt.,Vernon, Ky. , ...
... 19 Have you ever asked yourself, "What in the world ... safe to give your puppy a leftover turkey drumstick - or ... , , To address these and ... (AVMA) today launched a new podcast series, "Chew on This," dedicated ...
Cached Medicine News:Health News:UCAR weather forecasts aim to reduce African meningitis epidemics 2Health News:UCAR weather forecasts aim to reduce African meningitis epidemics 3Health News:Medipacs Chosen to Present at Invest Southwest Capital Conference 2Health News:Hagens Berman Files Class Action Against Bayer Healthcare Over Misleading Marketing Campaign 2Health News:Hagens Berman Files Class Action Against Bayer Healthcare Over Misleading Marketing Campaign 3Health News:Wendy Hoke Joins the Sisters of Charity Health System as Communications Officer 2Health News:Wendy Hoke Joins the Sisters of Charity Health System as Communications Officer 3Health News:HMS Presents 4th Annual Heroes of Healthcare Awards 2Health News:HMS Presents 4th Annual Heroes of Healthcare Awards 3Health News:AVMA Launches 'Chew on This' Podcast Series on Food Safety 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: